Provided by Tiger Trade Technology Pte. Ltd.

MBX Biosciences

53.24
-0.0100-0.02%
Post-market: 53.240.00000.00%19:30 EDT
Volume:538.78K
Turnover:28.56M
Market Cap:2.56B
PE:-22.14
High:53.82
Open:53.26
Low:51.89
Close:53.25
52wk High:72.64
52wk Low:12.94
Shares:48.16M
Float Shares:27.63M
Volume Ratio:1.14
T/O Rate:1.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4052
EPS(LYR):-2.3824
ROE:-33.17%
ROA:-22.08%
PB:6.26
PE(LYR):-22.35

Loading ...

MBX Biosciences is Maintained at Buy by Guggenheim

Dow Jones
·
Oct 02

MBX Biosciences price target raised to $150 from $88 at Guggenheim

TIPRANKS
·
Oct 02

Microbix Targets Growth Investors at Muskoka Capital Event

TIPRANKS
·
Sep 23

MBX Biosciences to Present at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 09

MBX Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Sep 09

Mbx Biosciences Announces Appointment of Jeff Held as Chief Legal Officer

THOMSON REUTERS
·
Sep 08

Press Release: MBX Biosciences Announces Appointment of Jeff Held as Chief Legal Officer

Dow Jones
·
Sep 08

MBX Biosciences Begins Pivotal Phase 3 Canvuparatide Trial

TIPRANKS
·
Aug 27

MBX Biosciences Doses First Patient in Phase 3 oPTimize Trial of Once-Weekly Canvuparatide for Hypoparathyroidism

Reuters
·
Aug 27

Mbx Biosciences, - Phase 3 Optimize Trial to Enroll About 160 Adults with Hypoparathyroidism

THOMSON REUTERS
·
Aug 27

MBX Biosciences Price Target Announced at $88.00/Share by JP Morgan

Dow Jones
·
Aug 22

U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions

Reuters
·
Aug 21

13D Filings

Dow Jones
·
Aug 15

Truist Adjusts Price Target on MBX Biosciences to $88 From $70, Maintains Buy Rating

MT Newswires Live
·
Aug 10

MBX Biosciences, Inc. (MBX) Gets a Buy from Mizuho Securities

TIPRANKS
·
Aug 08

MBX Biosciences price target raised to $88 from $70 at Barclays

TIPRANKS
·
Aug 07

Analysts Offer Insights on NA Companies: BillionToOne, Inc. Class A (BLLN) and MBX Biosciences, Inc. (MBX)

TIPRANKS
·
Aug 07

MBX Biosciences Shares Lower After Q2 Loss Widens

MT Newswires Live
·
Aug 06

MBX Biosciences, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

MBX Biosciences Advances Canvuparatide and Obesity Pipeline

TIPRANKS
·
Aug 06